Skip to Content

Publications Search - Abstract View

Title: No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls.
Authors: Sabunciyan S,  Mandelberg N,  Rabkin CS,  Yolken R,  Viscidi R
Journal: Mol Cell Probes
Date: 2011 Apr-Jun
Branches: IIB
PubMed ID: 21281710
PMC ID: PMC3285460
Abstract: New ELISA assays were developed to measure immunoreactivity for XMRV. Antibody titers were measured in a cohort of prostate cancer cases and cancer free controls from the central United States. No statistically significant differences were observed in immunoreactivity between cases and controls for either the XMRV-env or the XMRV-gag antigen.